Fords, NJ, United States of America

Jay M Matthews


Average Co-Inventor Count = 13.9

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jay M Matthews

Introduction

Jay M Matthews, an accomplished inventor based in Fords, New Jersey, has made significant contributions to the field of cardiovascular treatments. With two patents to his name, Matthews demonstrates a commitment to advancing medical science through innovative solutions.

Latest Patents

Among Matthews' latest inventions are two notable patents focusing on phenoxyphenylacetic acid derivatives and biphenyl compounds. These compounds exhibit endothelin antagonist activity, proving beneficial in treating a variety of cardiovascular disorders, including hypertension, postischemic renal failure, and myocardial infarction. Moreover, they show potential in addressing inflammatory diseases, such as Raynaud's disease and asthma. His work underscores the impact of chemical innovations on health management and disease treatment.

Career Highlights

Jay M Matthews is associated with Merck & Company, Inc., a global leader in pharmaceuticals. His role at this esteemed organization allows him to collaborate with top professionals in the field, leveraging their collective expertise to drive forward medical innovations.

Collaborations

During his career, Matthews has worked alongside talented colleagues, including Scott W Bagley and Theodore P Broten. These collaborations highlight the importance of teamwork in the realm of innovation and the shared goal of improving patient outcomes through scientific advancements.

Conclusion

Jay M Matthews exemplifies the spirit of innovation within the pharmaceutical industry. His patents reflect a profound understanding of chemical applications in medicine, showcasing how dedicated inventors can contribute to solving complex health challenges. With ongoing support from organizations like Merck & Company, Inc., Matthews continues to pave the way for future advancements in cardiovascular therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…